S Mauss

414 total citations
17 papers, 300 citations indexed

About

S Mauss is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, S Mauss has authored 17 papers receiving a total of 300 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 10 papers in Epidemiology and 6 papers in Infectious Diseases. Recurrent topics in S Mauss's work include Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (5 papers). S Mauss is often cited by papers focused on Hepatitis C virus research (11 papers), Hepatitis B Virus Studies (9 papers) and Liver Disease Diagnosis and Treatment (5 papers). S Mauss collaborates with scholars based in Germany, United States and Estonia. S Mauss's co-authors include E Zehnter, C. Sarrazin, Holger Hinrichsen, Stefan Zeuzem, Thomas Berg, D. Hueppe, Heiner Wedemeyer, Michael P. Manns, Bernd Moeller and D Hüppe and has published in prestigious journals such as Hepatology, Journal of Hepatology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

S Mauss

16 papers receiving 287 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S Mauss Germany 7 245 216 60 30 30 17 300
Zunaira Awan Pakistan 10 277 1.1× 261 1.2× 49 0.8× 39 1.3× 21 0.7× 15 343
Montserrat Maldonado‐González Mexico 11 305 1.2× 332 1.5× 34 0.6× 37 1.2× 28 0.9× 26 432
Anne Varaut France 8 356 1.5× 383 1.8× 51 0.8× 17 0.6× 14 0.5× 10 446
Wolfgang Kauffmann Germany 4 272 1.1× 151 0.7× 91 1.5× 14 0.5× 13 0.4× 6 321
Sergio Scaccabarozzi Italy 6 334 1.4× 326 1.5× 44 0.7× 13 0.4× 57 1.9× 10 419
Leonie Grellier United Kingdom 5 145 0.6× 132 0.6× 45 0.8× 22 0.7× 24 0.8× 6 189
Fernando E. Membreno United States 8 627 2.6× 599 2.8× 126 2.1× 55 1.8× 39 1.3× 14 721
Rikita Hatia United States 8 254 1.0× 254 1.2× 36 0.6× 32 1.1× 13 0.4× 18 345
Eirum Chaudhri Japan 3 509 2.1× 437 2.0× 113 1.9× 26 0.9× 60 2.0× 3 531

Countries citing papers authored by S Mauss

Since Specialization
Citations

This map shows the geographic impact of S Mauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Mauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Mauss more than expected).

Fields of papers citing papers by S Mauss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S Mauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Mauss. The network helps show where S Mauss may publish in the future.

Co-authorship network of co-authors of S Mauss

This figure shows the co-authorship network connecting the top 25 collaborators of S Mauss. A scholar is included among the top collaborators of S Mauss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S Mauss. S Mauss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Buggisch, Peter, S Mauss, Bernd Weber, et al.. (2020). Barrieren der Hepatitis-C-Virus (HCV) Elimination in Deutschland: warum erhalten diagnostizierte Patienten keine Therapie?. Zeitschrift für Gastroenterologie. 2 indexed citations
2.
Vermehren, Johannes, S. Süsser, Julia Dietz, et al.. (2016). Retreatment of Patients who Failed Daa-Combination Therapies: Real-World Experience from a Large Hepatitis C Resistance Database. Journal of Hepatology. 64(2). S188–S188. 20 indexed citations
3.
Stahmeyer, Jona T., S. Rossol, Ahmed Abdelfattah, et al.. (2014). P1147 OUTCOMES AND COSTS OF TREATING HEPATITIS C WITH PROTEASE INHIBITORS: RESULTS FROM A MULTI-CENTRE STUDY. Journal of Hepatology. 60(1). S464–S465. 2 indexed citations
4.
Fischer, C, S Mauss, E Zehnter, et al.. (2012). Epidemiologie und Klinik von Patienten mit chronischer Hepatitis B (CHB) in Deutschland – Ergebnisse einer bundesweiten Querschnittstudie. Zeitschrift für Gastroenterologie. 50(1). 22–29. 15 indexed citations
5.
Petersen, J., Peter Buggisch, Albrecht Stoehr, et al.. (2011). 745 STOPPING LONG-TERM NUCLEOS(T)IDE ANALOGUE THERAPY BEFORE HBSAG LOSS OR SERO-CONVERSION IN HBEAG NEGATIVE CHB PATIENTS: EXPERIENCE FROM FOUR REFERRAL CENTERS IN GERMANY. Journal of Hepatology. 54. S299–S300. 2 indexed citations
6.
Nischalke, Hans Dieter, M. Vogel, S Mauss, et al.. (2010). 1172 GENETIC VARIATION IN IL28B RS 12979860 AND RESPONSE TO HCV-SPECIFIC TREATMENT IN HCV/HIV CO-INFECTED PATIENTS. Journal of Hepatology. 52. S453–S453. 3 indexed citations
7.
Lunzen, Jan van, Gerd Fätkenheuer, Thomas A. Lutz, et al.. (2010). Efficacy and safety of TDF/FTC‐containing, first‐line HAART in clinical practice: 3‐year data from the German outpatient cohort. Journal of the International AIDS Society. 13(S4). 1 indexed citations
8.
9.
Zeuzem, Stefan, Thomas Berg, Bernd Moeller, et al.. (2008). Expert opinion on the treatment of patients with chronic hepatitis C. Journal of Viral Hepatitis. 16(2). 75–90. 164 indexed citations
10.
Petersen, J., M.P. Manns, S Mauss, et al.. (2008). Tenofovir disoproxil fumarate (TDF) for the treatment of HBeAg-positive chronic Hepatitis B: Week 72 TDF data and week 24 Adefovir dipivoxil switch data (Study 103). Zeitschrift für Gastroenterologie. 46(9). 15 indexed citations
11.
Manns, M.P., Thomas Berg, Peter Buggisch, et al.. (2008). The antiviral response to Tenofovir disoproxil fumarate (TDF) is comparable in Lamivudine (LAM)-naïve and LAM-experienced subjects treated for chronic Hepatitis B (CHB). Zeitschrift für Gastroenterologie. 46(9). 4 indexed citations
12.
Witthöft, T, B Möller, K. H. Wiedmann, et al.. (2007). Safety, tolerability and efficacy of peginterferon alpha‐2a and ribavirin in chronic hepatitis C in clinical practice: The German Open Safety Trial. Journal of Viral Hepatitis. 14(11). 788–796. 44 indexed citations
13.
Mauss, S, Stefan Scholten, Eva Wolf, et al.. (2004). A prospective, controlled study assessing the effect of lopinavir on amprenavir concentrations boosted by ritonavir. HIV Medicine. 5(1). 15–17. 8 indexed citations
14.
15.
Gabriëls, Gert, et al.. (2000). Involvement of protein phosphatases in differential regulation of renal proximal tubular PAH and sodium‐dependent dicarboxylate transport*. Fundamental and Clinical Pharmacology. 14(5). 501–507. 1 indexed citations
16.
Gabriëls, Gert, et al.. (1999). Evidence for Differential Regulation of Renal Proximal Tubular p-Aminohippurate and Sodium-Dependent Dicarboxylate Transport. Journal of Pharmacology and Experimental Therapeutics. 290(2). 710–715. 15 indexed citations
17.
Jablonowski, H, S Mauss, Hubert Szelényi, et al.. (1994). Rhodococcus equi pneumonia in an HIV-infected patient.. PubMed. 61(3). 206–9. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zunaira Awan Breakdown of academic impact, for papers by Montserrat Maldonado‐González Breakdown of academic impact, for papers by Anne Varaut Breakdown of academic impact, for papers by Wolfgang Kauffmann Breakdown of academic impact, for papers by Sergio Scaccabarozzi Breakdown of academic impact, for papers by Leonie Grellier Breakdown of academic impact, for papers by Fernando E. Membreno Breakdown of academic impact, for papers by Rikita Hatia Breakdown of academic impact, for papers by Eirum Chaudhri
Rankless by CCL
2026